Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials

David L Wirta, Michael S Korenfeld, Shane Foster, Robert Smyth-Medina, Jason Bacharach, Shane R Kannarr, Mark J Jaros, Charles B Slonim

Open source

DOI: 10.2147/opth.s322326
Published: 2021-10
Container: Clinical Ophthalmology
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2147/opth.s322326,
  title = {Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1\% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials},
  author = {David L Wirta and Michael S Korenfeld and Shane Foster and Robert Smyth-Medina and Jason Bacharach and Shane R Kannarr and Mark J Jaros and Charles B Slonim},
  year = {2021},
  journal = {Clinical Ophthalmology},
  doi = {10.2147/opth.s322326},
  url = {https://doi.org/10.2147/opth.s322326}
}

RIS

TY  - JOUR
TI  - Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials
AU  - David L Wirta
AU  - Michael S Korenfeld
AU  - Shane Foster
AU  - Robert Smyth-Medina
AU  - Jason Bacharach
AU  - Shane R Kannarr
AU  - Mark J Jaros
AU  - Charles B Slonim
PY  - 2021
JO  - Clinical Ophthalmology
DO  - 10.2147/opth.s322326
UR  - https://doi.org/10.2147/opth.s322326
ER  -

APA

Wirta, D. L., Korenfeld, M. S., Foster, S., Smyth-Medina, R., Bacharach, J., Kannarr, S. R., Jaros, M. J., & Slonim, C. B. (2021). Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials. Clinical Ophthalmology. https://doi.org/10.2147/opth.s322326

Source records

crossref · retrieved 2026-09-27T12:12:58.201Z